AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7862792 — intervention group
Group type: EXPERIMENTAL
Intervention: Alexithymic students
Number of subjects: 215
Study 2680085 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg once daily at bedtime for six weeks
Number of subjects: 163
Study 2680085 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study 785563 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10
Number of subjects: 18
Study 785563 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 785563 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 and Placebo
Number of subjects: 18
Study 31166952 — intervention group
Group type: EXPERIMENTAL
Intervention: Biannual oral azithromycin (20mg/kg for children, 1 g for adults)
Number of subjects: 455
Study 31166952 — intervention group
Group type: COMPARATOR
Intervention: No programmatic antibiotics (control group)
Number of subjects: 455
Study 27289068 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Music Engagement (AME + P)
Number of subjects: 16
Study 27289068 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 16
Study 26122078 — intervention group
Group type: EXPERIMENTAL
Intervention: Health warnings of smoking based on a specially designed leaflet and patient-centred counseling from nurse counselors with emphasis on risk perceptions of smoking to cancer prognosis, plus two telephone counseling sessions at 1-week and 1-month.
Number of subjects: 0
Study 26122078 — intervention group
Group type: COMPARATOR
Intervention: Standard care and a generic self-help smoking cessation booklet.
Number of subjects: 0
Study 23158886 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential treatment for 14 days (S-14)
Number of subjects: 900
Study 23158886 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential treatment for 10 days (S-10)
Number of subjects: 900
Study 23158886 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy for 14 days (T-14)
Number of subjects: 900
Study 22205452 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiberform granule for 2 weeks
Number of subjects: 121
Study 22205452 — intervention group
Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 121
Study 19932846 — intervention group
Group type: EXPERIMENTAL
Intervention: EJV preservation
Number of subjects: 38
Study 19932846 — intervention group
Group type: COMPARATOR
Intervention: EJV sacrifice
Number of subjects: 38
Study 16945895 — intervention group
Group type: EXPERIMENTAL
Intervention: Total-etching system (Etch 37 with One Step Plus)
Number of subjects: 10
Study 16945895 — intervention group
Group type: COMPARATOR
Intervention: Self-etching system (Tyrian SPE with One Step Plus)
Number of subjects: 10
Study 16945895 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthotropic fiber-reinforced composite (FRC) at the interface
Number of subjects: 10
Study 16945895 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel bonding
Number of subjects: 10
Study 16945895 — intervention group
Group type: COMPARATOR
Intervention: Dentin bonding
Number of subjects: 10
Study 15237267 — intervention group
Group type: COMPARATOR
Intervention: Meglumine antimoniate (MA)
Number of subjects: 104
Study 15237267 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc sulfate (ZS) 2%
Number of subjects: 104
Study 11408326 — intervention group
Group type: EXPERIMENTAL
Intervention: Cochlear implant patients
Number of subjects: 0
Study 11408326 — intervention group
Group type: COMPARATOR
Intervention: Normal hearing controls
Number of subjects: 0
Study 11408326 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 9425674 — intervention group
Group type: EXPERIMENTAL
Intervention: Better instances of the vowel /i/
Number of subjects: 0
Study 9425674 — intervention group
Group type: COMPARATOR
Intervention: Materials based on Kuhl's tokens of /i/
Number of subjects: 0
Study 9425674 — intervention group
Group type: EXPERIMENTAL
Intervention: Vowels developed from Kuhl's test set
Number of subjects: 0
Study 8514613 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT group (20 mg/m2 adriamycin i.v. on days 1 and 8, 100 mg cyclophosphamide p.o. on days 1-14, 20 mg tamoxifen p.o. daily)
Number of subjects: 82
Study 8514613 — intervention group
Group type: COMPARATOR
Intervention: ACM group (20 mg/m2 adriamycin i.v. on days 1 and 8, 100 mg cyclophosphamide p.o. on days 1-14, 1200 mg medroxyprogesterone acetate p.o. daily)
Number of subjects: 82
Study 3651272 — intervention group
Group type: EXPERIMENTAL
Intervention: Dideco Autotrans BT 795 autotransfusion device
Number of subjects: 41
Study 29242108 — intervention group
Group type: EXPERIMENTAL
Intervention: Access Only arm (discount, fresh F&V markets)
Number of subjects: 0
Study 29242108 — intervention group
Group type: EXPERIMENTAL
Intervention: Access Plus arm (markets plus educational components)
Number of subjects: 0
Study 29242108 — intervention group
Group type: COMPARATOR
Intervention: Comparison (attention placebo intervention on physical activity and stress reduction)
Number of subjects: 0
Study 27088277 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) using a neodymium-doped yttrium aluminum garnet (Nd:YAG) laser (1064 nm), applied immediately after surgery and every 24 hours for 4 days.
Number of subjects: 30
Study 27088277 — intervention group
Group type: COMPARATOR
Intervention: PBM sham (control group)
Number of subjects: 30
Study 25688495 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg once daily
Number of subjects: 123
Study 25688495 — intervention group
Group type: COMPARATOR
Intervention: Exemestane 25 mg once daily
Number of subjects: 123
Study 22171781 — intervention group
Group type: COMPARATOR
Intervention: Radiant warmer (group R)
Number of subjects: 130
Study 22171781 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm cotton blankets (group B)
Number of subjects: 130
Study 20425656 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory enhancement condition
Number of subjects: 53
Study 18673544 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethnicity-based risk score
Number of subjects: 1415
Study 18673544 — intervention group
Group type: COMPARATOR
Intervention: Age-based selection
Number of subjects: 1415
Study 18673544 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence of DM
Number of subjects: 1415
Study 17133471 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated interferon‐alpha‐2a and ribavirin
Number of subjects: 173
Study 12175452 — intervention group
Group type: EXPERIMENTAL
Intervention: Mint nicotine gum
Number of subjects: 0
Study 12175452 — intervention group
Group type: EXPERIMENTAL
Intervention: Original nicotine gum
Number of subjects: 0
Study 12175452 — intervention group
Group type: COMPARATOR
Intervention: Amphetamine (positive control)
Number of subjects: 0
Study 12175452 — intervention group
Group type: COMPARATOR
Intervention: Confectionery gum (positive control)
Number of subjects: 0
Study 10439886 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitoxin (N = 8)
Number of subjects: 16
Study 10439886 — intervention group
Group type: COMPARATOR
Intervention: Trichlormethiazide/amiloride (N = 8)
Number of subjects: 16
Study 7876852 — intervention group
Group type: EXPERIMENTAL
Intervention: TRH analogue (RX77368)
Number of subjects: 30
Study 7876852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 2222277 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin
Number of subjects: 30
Study 2222277 — intervention group
Group type: COMPARATOR
Intervention: Adjustable suture surgery
Number of subjects: 30
Study 18491 — intervention group
Group type: EXPERIMENTAL
Intervention: SCH 16134 (new benzodiazepine hypnotic)
Number of subjects: 10
Study 18491 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31446189 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor deposits
Number of subjects: 9246
Study 31446189 — intervention group
Group type: EXPERIMENTAL
Intervention: Both tumor deposits and lymph node metastases
Number of subjects: 9246
Study 31446189 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival
Number of subjects: 9246
Study 30952212 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia disorder (diagnosed using ICSD-2 criteria)
Number of subjects: 4717
Study 30952212 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger age categories
Number of subjects: 4717
Study 30952212 — intervention group
Group type: EXPERIMENTAL
Intervention: Worse self-rated health
Number of subjects: 4717
Study 30952212 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 4717
Study 28359716 — intervention group
Group type: EXPERIMENTAL
Intervention: O-3FA ethyl esters (750 mg/d DHA and 1860 mg/d EPA)
Number of subjects: 100
Study 28359716 — intervention group
Group type: COMPARATOR
Intervention: Standard statin therapy
Number of subjects: 100
Study 26171113 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX (group D)
Number of subjects: 60
Study 26171113 — intervention group
Group type: COMPARATOR
Intervention: midazolam (group M)
Number of subjects: 60
Study 23200601 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week group exercise and self-management programme facilitated by a physiotherapist in primary care
Number of subjects: 352
Study 23200601 — intervention group
Group type: COMPARATOR
Intervention: Standard GP care
Number of subjects: 352
Study 22199129 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplementation with fish oil (783 mg DHA, 162 mg EPA), bilberry extract (59 mg anthocyanidin), and lutein (17.5 mg) for 4 weeks
Number of subjects: 20
Study 22199129 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplementation with fish oil, bilberry extract, and lutein
Number of subjects: 20
Study 22199129 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules for 4 weeks
Number of subjects: 20
Study 19670077 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon dioxide (CO2) insufflation
Number of subjects: 30
Study 19670077 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 30
Study 16686608 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% permethrin cream
Number of subjects: 106
Study 15383019 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of iron(II) daily (Group A after first three donations)
Number of subjects: 260
Study 15383019 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of iron(II) daily (Group B after second three donations)
Number of subjects: 260
Study 15383019 — intervention group
Group type: COMPARATOR
Intervention: Placebo (both treatment groups during placebo phase)
Number of subjects: 260
Study 11296070 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam therapy (80‐100 mg/kg per day)
Number of subjects: 25
Study 11296070 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 11296070 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam therapy
Number of subjects: 25
Study 11009193 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 0
Study 11009193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8796815 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone 1 or 4 mg
Number of subjects: 0
Study 8796815 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8796815 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (both doses)
Number of subjects: 0
Study 8796815 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol, progesterone, and prolactin concentrations
Number of subjects: 0
Study 1537026 — intervention group
Group type: EXPERIMENTAL
Intervention: Glaxo strain of BCG
Number of subjects: 21
Study 1537026 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasteur strain of BCG
Number of subjects: 21
Study 6147080 — intervention group
Group type: EXPERIMENTAL
Intervention: Bucindolol
Number of subjects: 14
Study 6147080 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 14
Study 6147080 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Bucindolol and Hydrochlorothiazide
Number of subjects: 14
Study 6147080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 29953055 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsilgon-N (25 droplets thrice daily for 30 days) combined with 10 sessions of lagune cleansing using Tonsillor apparatus for 30 days
Number of subjects: 60
Study 29953055 — intervention group
Group type: COMPARATOR
Intervention: Control group with only 10 sessions of rinsing the palatine tonsil lagunes
Number of subjects: 60
Study 27238057 — intervention group
Group type: EXPERIMENTAL
Intervention: Idebenone (900 mg/day)
Number of subjects: 64
Study 27238057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 27238057 — intervention group
Group type: EXPERIMENTAL
Intervention: Idebenone
Number of subjects: 64
Study 24576440 — intervention group
Group type: EXPERIMENTAL
Intervention: Local application of dexamethasone 4 mg/1 mL on the inferior alveolar nerve during BSSO surgery
Number of subjects: 18
Study 24576440 — intervention group
Group type: COMPARATOR
Intervention: Control side (no dexamethasone applied)
Number of subjects: 18
Study 21474320 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmarch bandage exsanguination (Group A)
Number of subjects: 38
Study 21474320 — intervention group
Group type: COMPARATOR
Intervention: No Esmarch bandage exsanguination (Group B)
Number of subjects: 38
Study 20080545 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailor-made notched music treatment
Number of subjects: 8
Study 20080545 — intervention group
Group type: COMPARATOR
Intervention: Placebo notched music treatment
Number of subjects: 8
Study 17490472 — intervention group
Group type: EXPERIMENTAL
Intervention: First-generation antipsychotic medication
Number of subjects: 0
Study 17490472 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotic medication
Number of subjects: 0
Study 17490472 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 17490472 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cognitive performance
Number of subjects: 0
Study 16350770 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief interventions for alcohol misuse; characterized by low intensity and short duration (5-60 minutes).
Number of subjects: 0
Study 12410072 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental (EXP) delivery of methylphenidate (MPH)
Number of subjects: 0
Study 12410072 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrice-daily (TID) regimen of methylphenidate (MPH)
Number of subjects: 0
Study 12410072 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 0
Study 9704788 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-color fluorescent in situ hybridization analysis on flow-sorted cells for chromosomes X, Y, 13, 18, and 21
Number of subjects: 40
Study 9704788 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-color fluorescent in situ hybridization analysis
Number of subjects: 40
Study 7889635 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment
Number of subjects: 40
Study 7889635 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 1974206 — intervention group
Group type: EXPERIMENTAL
Intervention: epanolol 200 mg daily for 7 days
Number of subjects: 10
Study 1974206 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study 31627252 — intervention group
Group type: EXPERIMENTAL
Intervention: PCL for DSM‐IV (the PCL‐C)
Number of subjects: 1003
Study 31627252 — intervention group
Group type: EXPERIMENTAL
Intervention: Predicted PCL‐5 scores
Number of subjects: 1003
Study 31627252 — intervention group
Group type: EXPERIMENTAL
Intervention: Crosswalk's accuracy
Number of subjects: 1003
Study 29398646 — intervention group
Group type: EXPERIMENTAL
Intervention: Submergence-tolerant genotypes (Binadhan-11, Binadhan-12, RC 249, RC 251)
Number of subjects: 10
Study 29398646 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately tolerant genotypes (RC 192, RC 193, RC 225)
Number of subjects: 10
Study 29398646 — intervention group
Group type: COMPARATOR
Intervention: All genotypes under submergence stress
Number of subjects: 10
Study 29398646 — intervention group
Group type: EXPERIMENTAL
Intervention: Days to flowering
Number of subjects: 10
Study 29398646 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant height
Number of subjects: 10
Study 29398646 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular characterization with SSR markers (RM 24, SC3, SUB1)
Number of subjects: 10
Study 26823503 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete resection of contrast-enhancing tumor (N = 40)
Number of subjects: 105
Study 26823503 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual detection of contrast enhancement (N = 19)
Number of subjects: 105
Study 26823503 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery at first recurrence
Number of subjects: 105
Study 26823503 — intervention group
Group type: EXPERIMENTAL
Intervention: Incomplete tumor resection
Number of subjects: 105
Study 26823503 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life assessment
Number of subjects: 105
Study 24161568 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionation (HYPO) - 63 Gy/28 fractions for T1 and 67.5 Gy/30 fractions for T2
Number of subjects: 156
Study 24161568 — intervention group
Group type: COMPARATOR
Intervention: Conventional fractionation (CONV) - 66 Gy/33 fractions for T1 and 70 Gy/35 fractions for T2
Number of subjects: 156
Study 24161568 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionation (HYPO) for T1a disease
Number of subjects: 156
Study 24161568 — intervention group
Group type: COMPARATOR
Intervention: Conventional fractionation (CONV) for T1a disease
Number of subjects: 156
Study 22304887 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-day intensive treatment for panic disorder (PDA)
Number of subjects: 0
Study 19171717 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILS)
Number of subjects: 3234
Study 19171717 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 3234
Study 19171717 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3234
Study 18940490 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine associated to remifentanil
Number of subjects: 20
Study 18940490 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine associated to isoflurane
Number of subjects: 20
Study 16091146 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple Juice (AJ) 15 ml/kg twice daily
Number of subjects: 90
Study 16091146 — intervention group
Group type: EXPERIMENTAL
Intervention: White Grape Juice (WGJ) 15 ml/kg twice daily
Number of subjects: 90
Study 16091146 — intervention group
Group type: COMPARATOR
Intervention: Colored and flavored water (WA)
Number of subjects: 90
Study 12444941 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART (including indinavir, ritonavir, RTV/saquinavir)
Number of subjects: 168
Study 12444941 — intervention group
Group type: EXPERIMENTAL
Intervention: RTV or RTV/SQV
Number of subjects: 168
Study 10702653 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg titrated to Losartan 50 mg/Hydrochlorothiazide (HCT) 12.5 mg (n = 11)
Number of subjects: 25
Study 10702653 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg titrated to 10 mg (n = 14)
Number of subjects: 25
Study 8590958 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH‐antagonist (100 micrograms/100 ml saline over 75 min) administered in the morning
Number of subjects: 14
Study 8590958 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH‐antagonist (100 micrograms/100 ml saline over 75 min) administered in the evening
Number of subjects: 14
Study 8590958 — intervention group
Group type: COMPARATOR
Intervention: Control (physiological fluctuations in plasma GH)
Number of subjects: 14
Study 1717206 — intervention group
Group type: EXPERIMENTAL
Intervention: solution enriched with branched chain amino acid (45% BCAA)
Number of subjects: 27
Study 1717206 — intervention group
Group type: COMPARATOR
Intervention: balanced amino acid solution (24% BCAA)
Number of subjects: 27
Study 1717206 — intervention group
Group type: COMPARATOR
Intervention: dextrose
Number of subjects: 27
Study 6184569 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (160 mg thrice daily)
Number of subjects: 28
Study 6184569 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (20 mg slow release twice daily)
Number of subjects: 28
Study 30287324 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 26
Study 30287324 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 26
Study 27816732 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric aspiration performed after orthognathic surgery
Number of subjects: 24
Study 27816732 — intervention group
Group type: COMPARATOR
Intervention: Control group (no gastric aspiration)
Number of subjects: 24
Study 27816732 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric aspiration
Number of subjects: 24
Study 26208989 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients' subjective rating of mental health improvement from baseline to week 12
Number of subjects: 0
Study 26208989 — intervention group
Group type: COMPARATOR
Intervention: Objective improvement on the PANSS
Number of subjects: 0
Study 23841976 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Tape applied to hand and forearm for 6 days in combination with standard therapy
Number of subjects: 17
Study 23841976 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 17
Study 21349365 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent Inactivated Vaccine (TIV)
Number of subjects: 148
Study 21349365 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of TIV
Number of subjects: 148
Study 19307354 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cloxacillin for 6 weeks plus 2 weeks orally (p.o.)
Number of subjects: 50
Study 19307354 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rifampin‐cotrimoxazole for 8 weeks p.o.
Number of subjects: 50
Study 19307354 — intervention group
Group type: COMPARATOR
Intervention: Foreign-body maintenance
Number of subjects: 50
Study 19307354 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rifampin‐cotrimoxazole
Number of subjects: 50